The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
High Fragmentation Characterizes Tumour-Derived Circulating DNA
Open accessAbstract
BACKGROUND: Circulating DNA (ctDNA) is acknowledged as a potential diagnostic tool for various cancers including colorectal cancer, especially when considering the detection of mutations. Certainly due to lack of normalization of the experimental conditions, previous reports present many discrepancies and contradictory data on the analysis of the concentration of total ctDNA and on the proportion of tumour-derived ctDNA fragments. METHODOLOGY: In order to rigorously analyse ctDNA, we thoroughly investigated ctDNA size distribution. We used a highly specific Q-PCR assay and athymic nude mice xenografted with SW620 or HT29 human colon cancer cells, and we correlated our results by examining plasma from metastatic CRC patients. CONCLUSION/SIGNIFICANCE: Fragmentation and concentration of tumour-derived ctDNA is positively correlated with tumour weight. CtDNA quantification by Q-PCR depends on the amplified target length and is optimal for 60-100 bp fragments. Q-PCR analysis of plasma samples from xenografted mice and cancer patients showed that tumour-derived ctDNA exhibits a specific amount profile based on ctDNA size and significant higher ctDNA fragmentation. Metastatic colorectal patients (n = 12) showed nearly 5-fold higher mean ctDNA fragmentation than healthy individuals (n = 16).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments
Bustin, S. A., Benes, V., Garson, J. A., Hellemans, J., Huggett, J., Kubista, M., Mueller, R., Nolan, T., Pfaffl, M. W., Shipley, G. L., et al. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2008.112797 · Cited by 16,303
Jahr, S., Hentze, H., Englisch, S., Hardt, D., Fackelmayer, F. O., Hesch, R. D., & Knippers, R. (2001) · PubMed · Cited by 2,169
Detection and quantification of mutations in the plasma of patients with colorectal tumors
Diehl, F., Li, M., Dressman, D., He, Y., Shen, D., Szabo, S., Diaz, L. A., Goodman, S. N., David, K. A., Juhl, H., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507904102 · Cited by 1,188
Allegra, C. J., Jessup, J. M., Somerfield, M. R., Hamilton, S. R., Hammond, E. H., Hayes, D. F., McAllister, P. K., Morton, R. F., & Schilsky, R. L. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.21.9170 · Cited by 1,156 · cited 1×
“Studies are ongoing in our laboratory to follow these potential biomarkers along with KRAS/BRAF SNP detection in regards to the personalized anti-EGFR therapy for metastatic CRC [31].”
BackgroundSawyers, C. L. (2008) · Nature · doi:10.1038/nature06913 · Cited by 983
Circulating nucleic acids (CNAs) and cancer—A survey
Fleischhacker, M., & Schmidt, B. (2007) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2006.10.001 · Cited by 851
About the possible origin and mechanism of circulating DNA
Stroun, M., Lyautey, J., Lederrey, C., Olson-Sand, A., & Anker, P. (2001) · Clinica Chimica Acta · doi:10.1016/s0009-8981(01)00665-9 · Cited by 740
Size Distributions of Maternal and Fetal DNA in Maternal Plasma
Chan, K. C. A., Zhang, J., Hui, A. B. Y., Wong, N., Lau, T. K., Leung, T. N., Lo, K.-W., Huang, D. W. S., & Lo, Y. M. D. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2003.024893 · Cited by 584
Mutations in APC, Kirsten-ras, and p53—alternative genetic pathways to colorectal cancer
Smith, G., Carey, F. A., Beattie, J., Wilkie, M. J. V., Lightfoot, T. J., Coxhead, J., Garner, R. C., Steele, R. J. C., & Wolf, C. R. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.122612899 · Cited by 521
Prediction of Breast Tumor Progression by Integrity of Free Circulating DNA in Serum
Umetani, N., Giuliano, A. E., Hiramatsu, S. H., Amersi, F., Nakagawa, T., Martino, S., & Hoon, D. S. B. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.05.9493 · Cited by 351
Cell-free DNA in the blood as a solid tumor biomarker–a critical appraisal of the literature
Jung, K., Fleischhacker, M., & Rabien, A. (2010) · Clinica Chimica Acta · doi:10.1016/j.cca.2010.07.032 · Cited by 337
Increased plasma DNA integrity in cancer patients.
Wang, B. G., Huang, H. Y., Chen, Y., Bristow, R. E., Kassauei, K., Cheng, C., Roden, R. B. S., Sokoll, L. J., Chan, D. W., & Shih, I. (2003) · PubMed · Cited by 326
Origin and quantification of circulating DNA in mice with human colorectal cancer xenografts
Thierry, A. R., Mouliere, F., Gongora, C., Ollier, J., Robert, B., Ychou, M., Del Rio, M., & Molina, F. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq421 · Cited by 299
Self-citationDetection and Monitoring of Cell‐Free DNA in Blood of Patients with Colorectal Cancer
Schwarzenbach, H., Stoehlmacher, J., Pantel, K., & Goekkurt, E. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1448.025 · Cited by 193
Circulating DNA: Its Origin and Fluctuation
Van Der Vaart, M., & Pretorius, P. J. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1448.022 · Cited by 190
Frattini, M., Gallino, G., Signoroni, S., Balestra, D., Lusa, L., Battaglia, L., Sozzi, G., Bertario, L., Leo, E., Pilotti, S., et al. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.03.021 · Cited by 142
Flamini, E., Mercatali, L., Nanni, O., Calistri, D., Nunziatini, R., Zoli, W., Rosetti, P., Gardini, N., Lattuneddu, A., Verdecchia, G. M., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1931 · Cited by 132
Ellinger, J., Albers, P., Müller, S. C., Von Ruecker, A., & Bastian, P. J. (2009) · BJU International · doi:10.1111/j.1464-410x.2008.08289.x · Cited by 112
Cell-Free Circulating DNA: Diagnostic Value in Patients With Testicular Germ Cell Cancer
Ellinger, J., Wittkamp, V., Albers, P., Perabo, F., Mueller, S. C., von Ruecker, A., & Bastian, P. J. (2008) · The Journal of Urology · doi:10.1016/j.juro.2008.08.118 · Cited by 108
Ellinger, J., Bastian, P. J., Haan, K., et al. (2007) · International Journal of Cancer · doi:10.1002/ijc.23057 · Cited by 95
Amount of DNA in plasma and cancer risk: A prospective study
Gormally, E., Hainaut, P. L., Caboux, É., Airoldi, L., Autrup, H. N., MALAVEILLE, C., Dunning, A. M., GARTE, S. J., Matullo, G., Overvad, K., et al. (2004) · International Journal of Cancer · doi:10.1002/ijc.20327 · Cited by 93
Decoding Circulating Nucleic Acids in Human Serum Using Microfluidic Single Molecule Spectroscopy
Liu, K. J., Brock, M. V., Shih, I., & Wang, T. (2010) · Journal of the American Chemical Society · doi:10.1021/ja100342q · Cited by 60
Deligezer, U., Eralp, Y., Akişık, E. E., Akisik, E. Z., Saip, P. M., Topuz, E., & Dalay, N. (2008) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2008.080 · Cited by 60
Circulating fragmented nucleosomal DNA and caspase-3 mRNA in patients with lymphoma and myeloma
Deligezer, U., Erten, N., Akişık, E. E., & Dalay, N. (2005) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2005.05.001 · Cited by 52
Integrity of Cell‐Free Plasma DNA in Patients with Lung Cancer and Nonmalignant Lung Disease
Schmidt, B., Weickmann, S., Witt, C. C., & Fleischhacker, M. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1448.034 · Cited by 48
Gongora, C., Candeil, L., Vezzio, N., Copois, V., Denis, V., Bareil, C., Molina, F., Fraslon, C., Fraslon, C., Conseiller, E., et al. (2008) · Cancer Biology & Therapy · doi:10.4161/cbt.7.6.5838 · Cited by 40
Self-citationGuadalajara, H., Domínguez–Berzosa, C., García‐Arranz, M., Herreros, M. D., Pascual, I., Baro, R. S., García-Olmo, D. C., & García‐Olmo, D. (2008) · Cancer Detection and Prevention · doi:10.1016/j.cdp.2008.01.002 · Cited by 26
CA19-9 epitope a possible marker for MUC-1/Y protein
Akagi, J., Takai, E., Tamori, Y., Nakagawa, K., & Ogawa, M. (2001) · International Journal of Oncology · doi:10.3892/ijo.18.5.1085 · Cited by 22
Cited by
Liquid biopsies come of age: Towards implementation of circulating tumour DNA
Wan, J. C. M., Massie, C., Garcia-Corbacho, J., Mouliere, F., Brenton, J. D., Caldas, C., Pacey, S., Baird, R., & Rosenfeld, N. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2017.7 · Cited by 2,809
Self-citationLiquid Biopsies: Genotyping Circulating Tumor DNA
Diaz, L. A., & Bardelli, A. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2012.45.2011 · Cited by 2,210
Liquid biopsy: monitoring cancer-genetics in the blood
Crowley, E., Di Nicolantonio, F., Loupakis, F., & Bardelli, A. (2013) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2013.110 · Cited by 1,819
Genome-wide cell-free DNA fragmentation in patients with cancer
Cristiano, S., Leal, A., Phallen, J., Fiksel, J., Adleff, V., Bruhm, D. C., Jensen, S. Ø., Medina, J. E., Hruban, C., White, J. R., et al. (2019) · Nature · doi:10.1038/s41586-019-1272-6 · Cited by 1,476
Enhanced detection of circulating tumor DNA by fragment size analysis
Mouliere, F., Chandrananda, D., Piskorz, A. M., Moore, E. K., Morris, J., Ahlborn, L. B., Mair, R., Goranova, T., Marass, F., Heider, K., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aat4921 · Cited by 1,069
Self-citation
Metadata
- Authors
- Mouliere, F., Robert, B., Arnau Peyrotte, E., Del Rio, M., Ychou, M., Molina, F., Gongora, C., & Thierry, A. R.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2011-09-06
- Volume
- 6
- Issue
- 9
- Pages
- e23418
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2014882257
- Cited by
- 567
- References
- 28
- FWCI
- 3.14
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.